Luckey et al., 2025(The Lancet): An international, randomised, controlled, open-label, phase 3, non-inferiority clinical trial was conducted. The study evaluated the efficacy and safety of zoliflodacin versus ceftriaxone plus azithromycin in patients aged 12 years and older with clinical suspicion of uncomplicated urogenital gonorrhoea. Eligible participants were randomly assigned (2:1) […]
Zhang et al 2026 (JAMA): A large long-term study followed over 131,821 people from Nurses’ Health Study and the Health Professionals for up to 43 years to examine whether drinking coffee or tea affects the risk of dementia. During the study 11,033 develop dementia. Study revealed that higher caffeinated coffee […]
Luciano et al., 2025 (N Engl J Med): A randomized, double-blind, placebo-controlled trial of shunt surgery was conducted among 99 participants having idiopathic normal pressure hydrocephalus (iNPH). It was observed that shunt surgery increases the gait velocity and was found unchanged in the placebo. A significant difference favoring shunt surgery […]
Estrella et al 2025(JAMA): A Meta-Analysis of 821327 outpatient participants and nearly 39 639 hospitalized patients who had both creatinine and cystatin C based eGFR measurements were conducted. Participants were followed for an average of 11 years to evaluate long term outcomes. The analysis showed that approximately 11% of outpatients and […]
Wharton et al., 2025 (N Engl J Med): In a phase 3 multinational, randomized, double-blind trial, Orforglipron, a small-molecule, nonpeptide GLP-1 receptor agonist, was investigated as a treatment for obesity. The safety and efficacy of orforglipron at doses (mg) of 6, 12, or 36 once-daily, as compared with placebo (assigned […]
Healthline, New Delhi, September 2024: Recent research indicates that glucagon-like peptide-1 (GLP-1) receptor agonist drugs, such as Ozempic and Mounjaro, could prevent up to 34,000 heart attacks and strokes annually in the U.S. These medications, traditionally used for diabetes and obesity, have demonstrated cardiovascular benefits in previous trials for individuals […]
Healthline, New Delhi, September 2024: A study published in Neurology reveals that the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet, which combines the Mediterranean diet and the Dietary Approaches to Stop Hypertension (DASH) diet, can slow cognitive decline, particularly in women. This new research has shown that adherence to the […]
Science News, August, 2024: COVID-19 diarrhea is a common symptom in people who contract the virus, with up to half experiencing it. About 30% of those who develop long COVID will also experience debilitating symptoms such as chronic pain, brain fog, shortness of breath, chest pain, and intense fatigue. The […]
Science News, August, 2024: The body’s biggest organ and an essential part of the immune system, the skin is shielded from the damaging effects of ultraviolet (UV) radiation by melanin. Tyrosinase is an essential component of the biosynthetic pathway, which is how melanocytes produce melanin in response to UV radiation […]
Science News, August, 2024: Scientists have identified and produced a class of chemicals that can function in an innovative manner against tuberculosis causation. They explain that, in contrast to antibiotics already in use, the so-called callyaerins combat infectious diseases through a radically different method. The callyaerins target Rv2113, a particular […]